Key result
High serum phosphate is linked to ~44% higher cardiovascular mortality and subclinical atherosclerosis.
Meta-Analysis
Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis demonstrate elevated serum phosphate increases cardiovascular risks, implying potential health concerns.
(1) Background: Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide. The aim of the study was to examine the existing published results of the association between elevated serum phosphate concentrations and cardiovascular mortality, along with the CVD incidence and subclinical coronary atherosclerosis, in primary prevention among non-selected samples of the general population. (2) Methods: A systematic review and meta-analysis were carried out using literature obtained from PubMed, SCOPUS, and the Web Of Science until March 2024 and following the PRISMA guidelines. Relevant information was extracted and presented. Random and fixed effects models were used to estimate the pooled odds ratio (OR) and hazard ratio (HR) with their 95% coefficient interval (CI), and I2 was used to assess heterogeneity. (3) Results: Twenty-five studies met our inclusion criteria and were included in the meta-analysis (11 cross-sectional and 14 cohort studies). For cardiovascular mortality, which included 7 cohort studies and 41,764 adults, the pooled HR was 1.44 (95% CIs 1.28, 1.61; I2 0%) when the highest versus the reference level of serum phosphate concentrations were compared. For CVDs, which included 8 cohort studies and 61,723 adults, the pooled HR was 1.12 (95% CIs 0.99, 1.27; I2 51%). For subclinical coronary atherosclerosis, which included 11 cross-sectional studies and 24,820 adults, the pooled OR was 1.44 (95% CIs 1.15, 1.79; I2 88%). (4) Conclusions: The highest serum phosphate concentrations were positively associated with a 44% increased risk of cardiovascular mortality and subclinical coronary atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Torrijo-Belanche et al. (2024) conducted a meta-analysis in Cardiovascular mortality, cardiovascular diseases, and subclinical coronary atherosclerosis. Highest serum phosphate concentrations vs. Reference level of serum phosphate concentrations was evaluated on Cardiovascular mortality (HR 1.44, 95% CI 1.28-1.61). High serum phosphate concentrations were associated with increased cardiovascular mortality and subclinical coronary atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: